Neurocrine Biosciences reported $1.85B in Assets for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acadia Pharmaceuticals ACAD:US $ 755.17M 27.44M
Acorda Therapeutics ACOR:US $ 584.05M 48.63M
Adamas Pharmaceuticals ADMS:US 169.25M 49.22M
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
ALKERMES ALKS:US $ 1937.57M 59.35M
Alnylam Pharmaceuticals ALNY:US $ 3255.27M 151.79M
Amgen AMGN:US $ 62539M 409M
Aptinyx Inc APTX:US $ 152.89M 2.28M
Biogen BIIB:US $ 24470.4M 615.7M
Biomarin Pharmaceutical BMRN:US $ 5898.5M 93.44M
Cytokinetics CYTK:US $ 577.06M 43.26M
Dynavax Technologies DVAX:US $ 490.12M 136.85M
Enanta Pharmaceuticals ENTA:US $ 467.77M 13.24M
Exelixis EXEL:US $ 2190.54M 53.21M
Gilead Sciences GILD:US $ 67984M 492M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Halozyme Therapeutics HALO:US $ 966.58M 386.66M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
Intra Cellular Therapies ITCI:US $ 674.49M 42.82M
Nektar Therapeutics NKTR:US $ 1456.56M 82.21M
Neurocrine Biosciences NBIX:US $ 1846.4M 111.7M
Prothena PRTA:US $ 379.72M 46.74M
Regeneron Pharmaceuticals REGN:US $ 17772.2M 608.9M
Repligen RGEN:US $ 2015.96M 88.64M
Rigel Pharmaceuticals RIGL:US $ 215.99M 105.62M
Sarepta Therapeutics SRPT:US $ 2765.23M 219.48M
Teva Pharmaceutical TEVA:IT 49.2B 191M
Ultragenyx Pharmaceutical RARE:US $ 1597.76M 161.79M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
Xoma XOMA:US $ 119.89M 5.39M
YTE INCY:US $ 3661.44M 100.52M
Zogenix ZGNX:US $ 580.96M 70.17M